Category Archives: IMS Data PharmaKing April 14 2008 for Week of April 4 2

A Quick Update — Courtesy of PharmaKing, here.

He’ll keep posting updates, so do go look, from time to time, here:

. . . .Here are the weekly IMS figures.

. . . .for the Week Ending April 4, 2008:

Vytorin — year over year:

New: -29%
Total: -20%
Market share (of New): 8.2%

Zetia — year over year:

New -26%
Total -19%
Market share (of New) 4.8%

Crestor — year over year
[this is an AstraZeneca product]:

New +10%
Total +6%
Market share (of New) 9.5%


Wow. Each figure is a new record, both up and down.

H/T: PharmaKing

Advertisements

A Quick Update — Courtesy of PharmaKing, here.

He’ll keep posting updates, so do go look, from time to time, here:

. . . .Here are the weekly IMS figures.

. . . .for the Week Ending April 4, 2008:

Vytorin — year over year:

New: -29%
Total: -20%
Market share (of New): 8.2%

Zetia — year over year:

New -26%
Total -19%
Market share (of New) 4.8%

Crestor — year over year
[this is an AstraZeneca product]:

New +10%
Total +6%
Market share (of New) 9.5%


Wow. Each figure is a new record, both up and down.

H/T: PharmaKing

A Quick Update — Courtesy of PharmaKing, here.

He’ll keep posting updates, so do go look, from time to time, here:

. . . .Here are the weekly IMS figures.

. . . .for the Week Ending April 4, 2008:

Vytorin — year over year:

New: -29%
Total: -20%
Market share (of New): 8.2%

Zetia — year over year:

New -26%
Total -19%
Market share (of New) 4.8%

Crestor — year over year
[this is an AstraZeneca product]:

New +10%
Total +6%
Market share (of New) 9.5%


Wow. Each figure is a new record, both up and down.

H/T: PharmaKing